This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab | MicrobiomeTrials
← Back to trials NCT07276100
Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-01-01Est. Completion: 2027-01-01
Enrollment target: 15 participantsLocations IRCCS AOU di Bologna Policlinico di Sant'Orsola, Bologna, BO, Italy Other microbiome trials you might be interested in Hepato Cellular Carcinoma
Conventional transarterial chemoembolization with Doxorubicin (c-TACE) is the gold standard treatment for Hepato Cellula…
Strasbourg, France Completed Oct 9, 2019
Hepato Cellular Carcinoma (HCC) Hand Foot Skin Syndrome
SHIELD is a single-center, open-label, single-arm prospective study designed to evaluate whether pre-emptive topical ind…
Taipei, Taiwan Est. completion Apr 30, 2029